1-3 of 3
Yaroslav Teper
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Opposite Effects of Src Family Kinases on YAP and ERK Activation in Pancreatic Cancer Cells: Implications for Targeted Therapy

Open Access
James Sinnett-Smith, Tarique Anwar, Elaine F. Reed, Yaroslav Teper, Guido Eibl, Enrique Rozengurt
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2022) 21 (11): 1652–1662.
https://doi.org/10.1158/1535-7163.MCT-21-0964
Published: 03 November 2022
View articletitled, Opposite Effects of Src Family Kinases on YAP and ERK Activation in Pancreatic Cancer Cells: Implications for Targeted Therapy
Open the PDF for Opposite Effects of Src Family Kinases on YAP and ERK Activation in Pancreatic Cancer Cells: Implications for Targeted Therapy in another window
Includes: Supplementary data
Journal Articles

T Cell–Mediated Antitumor Immunity Cooperatively Induced By TGFβR1 Antagonism and Gemcitabine Counteracts Reformation of the Stromal Barrier in Pancreatic Cancer

Open Access
Dandan Li, Nicholas Schaub, Theresa M. Guerin, Tashinga E. Bapiro, Frances M. Richards, Vicky Chen, Keyur Talsania, Parimal Kumar, Debra J. Gilbert, Jerome J. Schlomer, Seong-Jin Kim, Rebecca Sorber, Yaroslav Teper, Wendy Bautista, Claudia Palena, Chan-Young Ock, Duncan I. Jodrell, Nathan Pate, Monika Mehta, Yongmei Zhao, Serguei Kozlov, Udo Rudloff
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2021) 20 (10): 1926–1940.
https://doi.org/10.1158/1535-7163.MCT-20-0620
Published: 01 October 2021
View articletitled, T Cell–Mediated Antitumor Immunity Cooperatively Induced By TGFβR1 Antagonism and Gemcitabine Counteracts Reformation of the Stromal Barrier in Pancreatic Cancer
Open the PDF for T Cell–Mediated Antitumor Immunity Cooperatively Induced By TGFβR1 Antagonism and Gemcitabine Counteracts Reformation of the Stromal Barrier in Pancreatic Cancer in another window
Journal Articles

Target Deconvolution of a Multikinase Inhibitor with Antimetastatic Properties Identifies TAOK3 as a Key Contributor to a Cancer Stem Cell–Like Phenotype

Free
Yansong Bian, Yaroslav Teper, Lesley A. Mathews Griner, Taylor J. Aiken, Vivek Shukla, Rajarshi Guha, Paul Shinn, Hong-Wu Xin, Holger Pflicke, Astin S. Powers, Dandan Li, Jian-kang Jiang, Paresma Patel, Steven A. Rogers, Jeffrey Aubé, Marc Ferrer, Craig J. Thomas, Udo Rudloff
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2019) 18 (11): 2097–2110.
https://doi.org/10.1158/1535-7163.MCT-18-1011
Published: 01 November 2019
View articletitled, Target Deconvolution of a Multikinase Inhibitor with Antimetastatic Properties Identifies TAOK3 as a Key Contributor to a Cancer Stem Cell–Like Phenotype
Open the PDF for Target Deconvolution of a Multikinase Inhibitor with Antimetastatic Properties Identifies TAOK3 as a Key Contributor to a Cancer Stem Cell–Like Phenotype in another window
Includes: Supplementary data